Skip to content

QuarterlyIQ Insights · CNC

Factors

The full factor breakdown (the numbers behind each rank). The overview page shows the same reads in short form; this is the depth.

Factor signals

Each factor is a parallel diagnostic with a plain-language read of what it shows and how names like it have historically fared. Never aggregated into a single score.

Recent financial performance
weak

Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated weak grew net income 55% of the time over the next year (vs 54% for the rest of the cohort, n=2391).

14th pctl · Health Care
The numbers
bonus
0.1208
dir share
-0.6622
slope norm
0.4417
Earnings quality
loss_making

Over the trailing year it converted -1.23x of net income into operating cash flow.

The numbers
ttm ni
-6444
ttm cfo
7944
Macro sensitivity

Not enough signal yet.

Not enough signal to read sensitivity to the broad stock market, the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).

Management & capital allocation
volatile

18 material management or governance events in the past 24 months, led by M&A activity. Historically, Health Care names rated volatile grew net income 43% of the time over the next year (vs 57% for the rest of the cohort, n=600).

8th pctl · Health Care
The numbers
n events
18
raw activity
2.1392
directional rank
0.1589
directional status
capital_unfriendly

Not investment advice. As of 2026-06-09.

Earnings setup & market context

The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.

Earnings setup · pre-print positioning
forward-looking
bullish7 PT revisions / 30d, avg 12.1% above currentfor period ending 2026-06-30
Why this setup
Consensus revisions

EPS estimate $1.07 → $1.05 (-1.2% / 30d). 7 raised, 10 cut, 17 covering analysts.

Rating actions

1 upgrade, 0 downgrades / 30d, 7 maintained. 35% of analysts rate Buy.

Price target activity

7 PT revisions / 30d. Avg target 12.1% above current price.

Material events

0 positive, 0 negative / 30d.

Transition story with positive analyst positioning (often a turnaround setup).

Sector context
Intermediate · Weekly
Sector phase: health care is in growth, with decelerating (~2.5 years in phase).
Sector regime (90d momentum): headwind.
headwind-9.2%sector vs S&P 500, 60d

via XLV

Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.

Full health care context →All sectors →

AI cycle regime · market-wide
2-axis classifierLong-term · 1–3 yr
HeatingManiaSquallCrisisEarnings →Mood ↑
HeatingE -0.23 · M +0.31
Single-axisneutralz +0.26

Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.

Not investment advice. As of 2026-06-09.